No definition available.
Arteriovenous malformation of cerebral vessels
Q17_ARTERIOVENOUS_MALFORMATION_OF_CEREBRAL_VESSELS
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
437 |
4. Check minimum number of eventsNone |
437 |
5. Include endpointsNone |
437 |
6. Filter based on genotype QC (FinnGen only) |
392 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Similar endpoints
↥List of similar endpoints to
Arteriovenous malformation of cerebral vessels
based on the number of shared cases.
Similar with more cases:
- Other congenital malformations of circulatory system
- Congenital malformations of the circulatory system
- Congenital malformations, deformations and chromosomal abnormalities
- Congenital malformations, deformations and chromosomal abnormalities, including avohilmo
- Any operation in hilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 392 | 209 | 183 |
| Unadjusted period prevalence (%) | 0.08 | 0.07 | 0.08 |
| Median age at first event (years) | 55.40 | 53.53 | 57.55 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 409
- Matched controls
- 4090
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q28.2
ICD-10 Finland
Arteriovenous malformation of cerebral vessels
+∞
307.7
409
*
PA2BC
NOMESCO Finland
Cerebral extensive angiography with X-ray
102.4
214.3
112
15
Q28.3
ICD-10 Finland
Other malformations of cerebral vessels
611.0
100.0
95
*
PA2CC
NOMESCO Finland
Cerebral very extensive angiography with X-ray
164.8
98.1
100
8
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
12.5
88.2
97
99
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
25.9
83.4
60
27
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
8.0
73.6
122
207
AAC40
NOMESCO Finland
Extirpation of intracranial arterio-venous malformation
+∞
72.0
67
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
15.2
70.8
66
51
AA1AD
NOMESCO Finland
CT of head and brain
5.7
69.0
238
798
N03AF02
ATC
oxcarbazepine; oral
13.6
68.0
68
59
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
24.6
63.2
46
21
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
17.9
53.7
45
28
PA2JT
NOMESCO Finland
Very extensive embolisation of arterio-venous malformation of the brain
+∞
51.1
48
*
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
13.5
46.0
45
37
PA2AC
NOMESCO Finland
Cerebral angiography with X-ray
65.9
45.6
52
9
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
17.8
43.2
36
22
I60.8
ICD-10 Finland
Other subarachnoid haemorrhage
155.5
40.6
42
*
PA2HT
NOMESCO Finland
Extensive embolisation of arterio-venous malformation of the brain
+∞
39.2
37
*
N03AX14
ATC
levetiracetam; systemic
10.0
37.6
45
50
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
4.9
37.0
97
244
G40.9
ICD-10 Finland
Epilepsy, unspecified
8.6
37.0
50
65
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
10.9
35.0
39
39
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
11.5
33.6
36
34
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.9
31.3
117
381
PA2GT
NOMESCO Finland
Embolisation of arterio-venous malformation of the brain
+∞
30.6
29
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.7
29.1
121
421
XA800
NOMESCO Finland
Neuropsychological investigation
6.0
27.4
52
97
N03AF01
ATC
carbamazepine; oral, rectal
5.6
26.7
55
111
H93.1
ICD-10 Finland
Tinnitus
4.6
25.8
68
169
PA3AC
NOMESCO Finland
Carotis angiography with X-ray
59.9
24.3
28
5
H53.4
ICD-10 Finland
Visual field defects
8.6
24.2
32
40
R56.8
ICD-10 Finland
Other and unspecified convulsions
5.5
23.7
49
99
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
53.1
21.4
25
5
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
16.7
19.6
31
20
R51.80
ICD-10 Finland
Headache
3.0
19.4
106
425
WX882
NOMESCO Finland
High dependency care
8.0
19.3
27
36
PA2BG
NOMESCO Finland
MRI examination of vessels in the head with high intensity magnet
36.3
19.1
24
7
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
18.7
18.5
28
16
G40.10
ICD-10 Finland
Simple partial seizures
69.8
17.9
20
*
I61.8
ICD-10 Finland
Other intracerebral haemorrhage
+∞
17.8
17
*
XCK00
NOMESCO Finland
Perimetry
4.4
17.4
47
118
WX408
NOMESCO Finland
General anesthesy, balanced
2.5
16.5
143
719
PA2AD
NOMESCO Finland
CT angiography of brain
19.5
16.2
24
13
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
20.2
15.7
23
12
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
4.9
15.5
35
76
I61.1
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, cortical
22.0
14.8
21
10
AAL00
NOMESCO Finland
Endovascular occlusion of intracranial aneurysm
155.3
14.6
15
*
K90
ICPC
Stroke/cerebrovascular accident
6.7
14.2
23
36
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
15.2
14.2
23
16
Q28.8
ICD-10 Finland
Other specified congenital malformations of circulatory system
144.6
13.5
14
*
Q28.0
ICD-10 Finland
Arteriovenous malformation of precerebral vessels
144.6
13.5
14
*
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
10.2
13.4
26
27
N03AG01
ATC
valproic acid; systemic, rectal
3.8
13.2
43
124
PA4AC
NOMESCO Finland
Vertebralis angiography with X-ray
51.7
12.9
15
*
I77.0
ICD-10 Finland
Arteriovenous fistula, acquired
72.2
12.7
14
*
XX4AW, ,
NOMESCO Finland
133.9
12.5
13
*
D18.0
ICD-10 Finland
Haemangioma, any site
6.1
12.4
22
38
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.2
12.2
53
184
AAF00
NOMESCO Finland
Ventriculostomy
27.7
12.1
16
6
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
4.8
11.8
27
59
PA5JT
NOMESCO Finland
Embolisation of very extensive arterio-venous malformation of carotis externa area
+∞
11.5
11
*
AAB30
NOMESCO Finland
Evacuation of spontaneous intracranial haematoma
+∞
11.5
11
*
R51
ICD-10 Finland
Headache
3.7
11.4
38
111
ZXE20
NOMESCO Finland
More than three and less than five hours
2.6
11.1
75
330
AA5PD
NOMESCO Finland
CT examination of brain pefusion
16.1
10.9
17
11
I60.9
ICD-10 Finland
Subarachnoid haemorrhage, unspecified
8.9
10.7
22
26
I69.0
ICD-10 Finland
Sequelae of subarachnoid haemorrhage
14.7
10.6
17
12
PA5AC
NOMESCO Finland
Angiography of arteries to the face with X-ray
+∞
10.5
10
*
Z2445
NOMESCO Finland
Psychologist
3.8
10.4
33
93
ZXD35
NOMESCO Finland
Usual procedure
4.5
10.2
25
58
H53.2
ICD-10 Finland
Diplopia
4.7
10.2
24
54
I61.4
ICD-10 Finland
Intracerebral haemorrhage in cerebellum
41.1
10.0
12
*
ZX050
NOMESCO Finland
Stereotactic radiotherapy
17.2
9.9
15
9
N03AX18
ATC
lacosamide; systemic
17.2
9.9
15
9
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.3
9.6
37
119
7478X
ICD-9 Finland
Other congenital anomalies of circulatory system, Other specified anomalies of circulatory system
+∞
9.4
9
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.3
9.1
82
408
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
2.9
8.8
43
159
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.6
8.8
29
84
Z3231
NOMESCO Finland
Registered nurse
2.0
8.6
125
744
ZXC95
NOMESCO Finland
Use of surgical navigator
9.7
8.3
16
17
AAC00
NOMESCO Finland
Ligature of intracranial aneurysm
10.3
8.1
15
15
183
Kela drug reimbursment
Lamotrigin and topiramate
10.3
8.1
15
15
R20.2
ICD-10 Finland
Paraesthesia of skin
2.8
8.1
42
161
XXA00
NOMESCO Finland
Clinical examination requiring general anaesthesia
22.5
8.1
11
5
I60.0
ICD-10 Finland
Subarachnoid haemorrhage from carotid siphon and bifurcation
22.5
8.1
11
5
ZXE10
NOMESCO Finland
More than one and less than three hours
1.8
7.9
158
1042
PA2CG
NOMESCO Finland
Extensive MRI examination of vessels in the head with high intensity magnet
45.9
7.7
9
*
AAC30
NOMESCO Finland
Intracranial occlusion of vascular fistula
81.5
7.4
8
*
AA9CW, ,
NOMESCO Finland
81.5
7.4
8
*
R4150
NOMESCO Finland
Neuropsychological rehabilitation
8.6
7.4
15
18
N18
ICPC
Paralysis/weakness
7.0
7.4
17
25
N03AB02
ATC
phenytoin; systemic
7.0
7.4
17
25
Q28.1
ICD-10 Finland
Other malformations of precerebral vessels
+∞
7.3
7
*
Q82.2
ICD-10 Finland
Mastocytosis
+∞
7.3
7
*
ZXD10
NOMESCO Finland
Scheduled procedure
1.8
7.2
158
1064
PA2LT
NOMESCO Finland
Endovascular closure of extensive brain aneurysm
20.4
7.2
10
5
WX002
NOMESCO Finland
Sedation and analgesia
2.0
7.0
88
495
WF099
NOMESCO Finland
Other radiotherapy
11.2
6.8
12
11
N88
ICPC
Epilepsy
12.5
6.6
11
9
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
10.3
6.6
12
12
H53.1
ICD-10 Finland
Subjective visual disturbances
2.6
6.6
38
154
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
5.9
6.5
17
30
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
4.0
6.5
18
46
G40
ICD-10 Finland
Epilepsy
7.6
6.5
14
19
I61.5
ICD-10 Finland
Intracerebral haemorrhage, intraventricular
70.9
6.4
7
*
WX892
NOMESCO Finland
Monitored bed care
2.5
6.4
40
169
G44.2
ICD-10 Finland
Tension-type headache
2.1
6.3
66
346
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
9.5
6.3
12
13
ZXD05
NOMESCO Finland
Urgent procedure
1.8
6.1
130
859
NA1AD
NOMESCO Finland
Cervical spine CT examination
3.1
6.1
26
89
RS222, ,
NOMESCO Finland
8.8
6.1
12
14
XF400
NOMESCO Finland
ECG with 12 standard connections
2.0
6.0
67
360
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
40
19
23.23
53.88
2.1
1.8
—
—
—
0
0
179
865
2.90
24.01
2.4
2.4
—
—
—
0
0
103
415
2.98
18.66
13.0
9.9
1.02
0.84
mmol/l
0.22
84
354
202
1142
2.52
18.60
2.4
2.1
137.91
233.93
u/l
1.02
195
1089
260
1682
2.50
17.42
12.0
12.1
1.16
1.22
inr
1.13
220
1392
256
1689
2.38
15.75
3.0
2.9
—
—
estimate
—
0
0
240
1650
2.10
11.94
10.1
7.2
1.21
1.21
mmol/l
1.04
228
1535
290
2159
2.18
11.48
8.7
5.4
6.54
6.65
mmol/l
0.50
277
2055
254
1821
2.04
10.82
9.9
7.8
1.21
1.21
mmol/l
0.54
225
1586
19
18
11.01
10.38
3.5
3.4
28.08
35.87
umol/l
0.76
13
12
96
505
2.18
9.33
10.5
7.5
105.38
104.30
mmol/l
1.48
96
505
198
1424
1.76
7.19
3.9
3.7
32.89
34.99
ng/l
0.05
148
1012
103
627
1.86
6.43
3.9
3.6
0.83
0.82
mmol/l
0.36
96
604
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
24
88
2.83
5.03
2.6
2.5
0.36
0.35
iu/ml
0.06
13
47
96
632
1.68
4.44
3.4
3.0
1.91
0.86
e6/l
1.48
60
331
277
2339
1.57
4.32
5.4
4.6
—
392.02
—
0
41
37
186
2.09
3.98
1.4
1.4
—
—
—
0
0
55
318
1.84
3.97
3.8
3.6
4.75
4.56
kpa
0.30
55
310
40
209
2.01
3.88
1.6
1.7
—
—
—
0
0
62
379
1.75
3.72
3.6
4.1
5.79
5.70
kpa
0.36
62
370
42
227
1.95
3.71
2.7
3.5
24.45
24.18
mmol/l
0.32
42
227
117
842
1.55
3.69
1.9
1.6
1.07
1.22
mg/l
0.32
100
672
237
1977
1.47
3.59
7.3
6.9
11.10
11.64
umol/l
0.29
225
1886
38
203
1.96
3.48
2.8
3.2
0.62
0.61
%
0.11
38
203
49
290
1.78
3.29
1.8
2.4
6.45
7.20
ug/l
0.12
44
264
137
1048
1.46
3.15
4.2
3.2
0.47
0.38
e6/l
0.18
105
759
385
3623
2.07
3.09
26.6
18.2
139.47
139.71
mmol/l
0.97
379
3568
6
8
7.59
3.06
1.7
1.6
18.12
16.71
umol/l
—
6
8
367
3420
1.71
2.80
20.0
14.9
84.66
82.81
ml/min/173m2
0.98
344
3155
9
23
3.98
2.79
3.2
2.7
0.78
0.87
index
—
9
23
72
496
1.55
2.72
5.3
6.2
1.05
1.04
mmol/l
0.07
66
468
21
99
2.18
2.69
2.0
1.2
9.54
22.24
e6/l
0.52
13
72
83
592
1.50
2.67
1.9
2.0
—
—
—
0
0
21
100
2.16
2.63
2.0
1.2
623.14
142.90
e6/l
0.54
14
77
24
122
2.03
2.56
1.2
1.9
—
—
—
0
0
383
3628
1.88
2.54
26.5
18.4
3.97
3.97
mmol/l
0.00
376
3566
37
219
1.76
2.51
5.6
4.2
0.67
1.65
mmol/l
0.94
26
163
42
259
1.69
2.48
1.5
1.6
—
—
—
0
0
192
1611
1.36
2.46
4.7
5.2
35.37
35.98
g/l
0.74
183
1530
63
437
1.52
2.31
3.3
2.8
10.90
8.03
umol/l
0.37
52
386
54
362
1.57
2.30
2.4
2.6
36.23
44.31
u/l
0.26
47
303
280
2506
1.37
2.29
4.2
3.4
57.26
49.09
u/l
0.57
268
2381
43
275
1.63
2.22
4.3
4.2
1.22
1.23
mmol/l
0.17
38
245
5
10
5.05
2.07
2.2
1.9
—
—
—
0
0
185
1575
1.32
2.03
1.8
2.1
94.24
96.02
pmol/l
0.22
91
828
14
63
2.27
2.03
1.9
1.3
—
—
—
0
0
14
63
2.27
2.03
1.9
1.3
—
—
—
0
0
33
202
1.69
2.03
1.1
1.0
—
—
—
0
0
11
44
2.54
2.02
1.9
2.8
4.07
4.07
mmol/l
0.03
11
44
11
44
2.54
2.02
1.9
2.8
105.00
105.30
mmol/l
0.12
11
44
11
44
2.54
2.02
1.9
2.8
1.20
1.19
mmol/l
0.08
11
44
373
3542
1.60
1.98
22.9
15.8
24.29
23.20
mg/l
0.26
332
2919
7
22
3.22
1.88
3.1
1.2
—
—
—
0
0
21
116
1.85
1.82
1.2
1.7
—
—
—
0
0
90
699
1.37
1.81
3.2
3.7
558.54
360.93
ng/l
0.22
67
535
389
3749
1.77
1.73
14.4
12.2
25.54
26.56
u/l
0.70
380
3660
77
588
1.38
1.72
3.5
3.1
3.98
2.03
e6/l
0.50
40
290
250
2250
1.29
1.69
2.8
3.2
—
—
—
0
0
141
1186
1.29
1.62
3.1
2.6
54.79
64.40
u/l
0.85
133
1110
7
26
2.72
1.58
1.4
2.0
—
—
—
0
0
60
448
1.40
1.54
2.1
1.9
—
—
—
0
0
6
21
2.88
1.51
1.2
1.5
93.67
106.00
%
—
6
21
22
132
1.70
1.49
2.2
3.1
—
—
—
0
0
7
28
2.53
1.46
1.1
1.3
186.96
176.08
pmol/l
—
7
28
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
16
3.15
1.44
1.8
2.9
128.60
132.06
%
—
5
16
50
366
1.42
1.44
2.7
2.5
0.22
0.22
g/l
0.00
45
341
56
422
1.38
1.37
2.2
2.0
—
—
—
0
0
16
90
1.81
1.35
1.5
1.3
—
—
—
0
0
40
285
1.45
1.34
2.7
2.6
78.90
68.07
ml/min/173m2
0.85
20
122
9
43
2.12
1.31
1.1
1.2
—
—
—
0
0
10
48
2.11
1.28
1.0
1.9
—
—
—
0
0
9
44
2.07
1.27
1.0
1.2
—
—
—
0
0
9
45
2.02
1.24
1.0
2.0
—
—
—
0
0
298
2795
1.24
1.17
9.8
8.5
79.63
79.08
u/l
0.07
290
2655
217
1979
1.21
1.10
4.4
3.8
0.00
0.82
estimate
0.50
31
366
110
942
1.23
1.05
2.4
2.1
2.74
2.89
mg/l
0.35
91
813
51
400
1.31
1.00
2.0
2.2
—
—
—
0
0
350
3366
1.28
0.96
4.4
4.3
1.31
1.29
mmol/l
0.23
326
3128
214
1967
1.18
0.94
4.5
3.7
43.29
0.00
estimate
0.49
38
397
54
431
1.29
0.94
3.9
4.9
30.90
32.23
%
0.40
39
293
12
70
1.74
0.93
1.0
1.1
0.30
2.68
u/ml
—
6
39
142
1264
1.19
0.90
3.0
3.5
2.36
2.35
mmol/l
0.43
125
1155
180
1636
1.18
0.89
2.3
2.5
77.31
77.24
nmol/l
0.01
162
1485
344
3310
1.25
0.88
5.5
5.2
1.83
1.89
mu/l
0.51
318
3070
50
400
1.28
0.86
7.6
6.7
—
—
—
0
0
229
2128
1.17
0.86
11.1
10.3
4.01
4.06
e9/l
0.14
202
1858
14
88
1.61
0.85
1.2
2.1
133.86
128.38
g/l
—
7
69
8
45
1.79
0.84
2.1
1.6
—
—
—
0
0
11
65
1.71
0.83
1.7
1.9
—
—
—
0
0
35
268
1.33
0.82
2.3
2.5
41.83
14.26
au/ml
—
6
17
47
377
1.28
0.80
4.1
3.2
—
—
—
0
0
210
1946
1.16
0.79
4.5
3.7
0.00
0.00
estimate
0.50
36
392
0
24
0.00
0.79
0.0
1.3
—
—
—
0
0
135
1209
1.17
0.79
4.2
4.1
4.89
9.50
mg/mmol
1.84
75
752
18
123
1.48
0.79
1.5
1.5
—
—
—
0
0
119
1055
1.18
0.78
1.5
1.7
21.61
20.77
nmol/l
0.21
99
898
11
67
1.66
0.76
1.2
1.2
30.62
22.65
u/l
0.26
11
57
9
54
1.68
0.75
1.0
1.1
—
—
—
0
0
7
40
1.76
0.71
1.4
1.7
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
26
1.93
0.71
1.0
1.1
—
—
—
0
0
16
111
1.46
0.67
1.2
1.3
—
—
—
0
0
5
28
1.80
0.66
1.0
1.0
—
—
—
0
0
68
584
1.20
0.65
2.5
2.4
2.28
2.31
g/l
0.13
62
539
64
547
1.20
0.64
2.4
2.4
23.08
22.67
%
0.08
58
511
9
140
0.63
0.61
1.1
1.5
1.03
1.20
g/l
—
9
134
15
105
1.44
0.61
2.0
1.5
—
—
—
0
0
139
1272
1.14
0.60
3.4
3.3
8.73
7.88
mmol/l
1.13
119
1074
393
3871
1.39
0.59
33.6
23.8
252.81
249.41
e9/l
0.43
386
3810
83
732
1.17
0.59
1.7
1.8
462.22
46926005.13
pmol/l
1.19
73
618
44
367
1.22
0.57
2.0
2.0
—
—
—
0
0
393
3873
1.38
0.56
33.5
23.8
4.47
4.52
e12/l
1.36
386
3802
6
39
1.55
0.53
1.3
1.3
—
—
—
0
0
16
117
1.38
0.53
1.3
1.5
—
—
—
0
0
7
107
0.65
0.49
2.1
1.9
187.57
229.08
pmol/l
—
7
100
67
754
0.87
0.47
3.4
3.0
0.66
0.72
ug/l
0.32
48
478
92
1010
0.89
0.45
4.3
4.4
21.94
21.76
%
0.05
40
465
15
112
1.35
0.45
1.9
1.5
346.50
266.34
ug/g
—
10
68
7
50
1.41
0.45
1.0
1.2
—
—
—
0
0
7
51
1.38
0.44
1.0
1.1
—
—
—
0
0
5
31
1.62
0.43
2.0
2.3
—
—
—
0
0
186
1762
1.10
0.42
2.9
2.9
148.63
118.04
ug/l
0.70
176
1661
14
105
1.35
0.41
1.9
1.7
—
—
—
0
0
0
15
0.00
0.41
0.0
1.6
—
42.01
—
0
15
0
16
0.00
0.41
0.0
1.2
—
171.54
—
0
16
159
1499
1.10
0.39
4.6
3.6
0.03
0.02
estimate
0.07
32
326
5
35
1.43
0.39
1.2
1.2
—
—
—
0
0
69
624
1.13
0.37
2.6
2.4
12.65
13.18
umol/l
0.23
63
577
15
190
0.78
0.36
1.2
1.3
—
—
—
0
0
287
2788
1.10
0.36
4.7
4.2
14.80
14.74
pmol/l
0.15
266
2562
5
79
0.63
0.36
1.2
1.4
—
—
—
0
0
18
145
1.25
0.34
1.4
1.5
14.38
8.96
u/ml
—
5
30
14
110
1.28
0.32
2.2
1.8
—
—
—
0
0
10
131
0.76
0.31
1.0
1.6
—
—
—
0
0
22
184
1.21
0.31
1.8
1.9
—
—
—
0
0
7
54
1.30
0.30
1.0
1.1
—
—
—
0
0
45
403
1.13
0.29
3.2
4.9
271.63
237.69
u/l
0.94
40
387
96
899
1.09
0.28
1.4
1.3
1.28
1.73
u/ml
0.20
25
248
15
122
1.24
0.27
2.5
2.1
67.33
5348.92
u/l
—
6
43
31
272
1.15
0.27
3.4
3.8
59.57
77.31
ng/l
1.53
26
242
26
225
1.17
0.26
1.7
2.0
—
—
—
0
0
10
77
1.31
0.26
1.8
1.5
—
—
—
0
0
9
73
1.24
0.25
1.3
1.4
—
231.43
—
0
7
59
640
0.91
0.25
1.3
1.3
16.80
9.80
u/ml
0.22
25
247
277
2707
1.07
0.25
4.9
4.4
11.08
11.23
mm/h
0.06
264
2533
12
96
1.26
0.25
1.4
1.4
123.75
229.13
pmol/l
0.37
12
91
11
137
0.80
0.24
2.5
1.6
196.64
317.94
mu/l
2.62
11
126
53
487
1.10
0.23
2.2
1.8
1.60
1.49
%
0.71
47
424
363
3587
1.11
0.23
5.7
5.9
2.66
2.72
mmol/l
0.56
340
3361
5
41
1.22
0.22
1.2
1.7
—
—
—
0
0
5
41
1.22
0.22
1.2
1.7
—
—
—
0
0
5
41
1.22
0.22
1.2
1.7
—
—
—
0
0
5
42
1.19
0.21
1.4
1.1
—
79.00
—
0
6
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
10
80
1.26
0.20
1.7
1.5
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
9.04
—
0
14
14
118
1.19
0.19
1.2
1.4
—
—
—
0
0
6
52
1.16
0.19
1.2
1.4
—
—
—
0
0
6
52
1.16
0.19
1.2
1.4
—
—
—
0
0
93
885
1.07
0.19
5.3
3.8
1.02
1.02
kg/l
0.37
60
599
6
53
1.13
0.18
1.2
1.4
—
—
—
0
0
7
58
1.21
0.18
1.3
1.4
—
—
—
0
0
74
701
1.07
0.17
1.4
1.6
—
—
—
0
0
10
82
1.23
0.17
2.6
1.6
—
—
—
0
0
11
130
0.84
0.16
1.5
1.6
774.86
974.89
mu/l
0.85
11
105
21
188
1.12
0.15
4.4
3.0
47.95
37.10
u/ml
0.17
21
177
357
3538
1.07
0.15
5.1
5.2
4.58
4.62
mmol/l
0.32
334
3321
27
246
1.10
0.15
1.4
1.3
39.26
147.20
u/ml
—
8
100
17
191
0.89
0.14
1.9
1.5
0.47
0.36
mg/l
—
10
82
58
551
1.06
0.13
1.5
1.5
—
—
—
0
0
10
116
0.86
0.12
1.1
1.2
—
—
—
0
0
107
1102
0.96
0.11
3.6
3.2
0.00
0.09
estimate
0.60
31
324
355
3526
1.05
0.10
5.0
5.1
1.46
1.45
mmol/l
0.10
332
3294
5
45
1.11
0.10
1.2
1.6
—
—
—
0
0
5
46
1.09
0.09
3.6
3.9
—
—
—
0
0
5
46
1.09
0.09
1.0
1.0
—
—
—
0
0
5
46
1.09
0.09
1.0
1.0
—
—
—
0
0
335
3374
0.96
0.09
6.6
6.4
38.75
39.15
mmol/mol
0.38
319
3191
6
54
1.11
0.09
1.2
1.4
—
—
—
0
0
6
54
1.11
0.09
1.2
1.4
—
—
—
0
0
6
54
1.11
0.09
1.2
1.4
—
—
—
0
0
41
391
1.05
0.08
3.9
4.6
9.19
18.33
ug/l
0.36
32
320
112
1095
1.03
0.08
3.5
3.1
862.32
1039.59
ng/l
0.41
97
916
7
66
1.06
0.08
2.7
1.6
—
—
—
0
0
14
127
1.11
0.08
1.4
1.2
0.83
0.89
g/l
0.37
14
127
123
1254
0.97
0.07
5.7
5.2
1.57
2.10
ug/l
1.11
114
1142
37
354
1.05
0.07
2.0
2.4
15.19
13.67
nmol/l
0.28
32
322
154
1563
0.98
0.06
1.9
2.0
1.33
1.36
mmol/l
0.21
134
1314
59
572
1.04
0.06
1.6
1.7
1078.88
1241.23
nmol/l
0.80
50
433
9
102
0.88
0.06
1.1
1.3
—
—
—
0
0
10
90
1.11
0.05
1.8
1.7
—
—
—
0
0
10
110
0.91
0.05
1.1
1.1
—
—
—
0
0
10
108
0.92
0.03
1.1
1.1
—
—
—
0
0
97
958
1.02
0.03
2.3
2.9
309.11
343.57
umol/l
3.36
87
857
69
701
0.98
0.02
1.3
1.3
18.54
33.09
iu/ml
1.34
17
222
12
114
1.05
0.00
1.5
1.4
—
—
—
0
0
11
106
1.04
0.00
1.3
1.3
—
—
—
0
0
343
3426
1.01
0.00
5.1
5.1
5.88
5.93
mmol/l
0.26
323
3184
109
1085
1.01
0.00
4.9
3.9
0.00
0.01
estimate
0.99
35
369
12
124
0.97
0.00
1.1
1.2
1.54
1.57
g/l
0.08
12
124
0
9
0.00
0.00
0.0
8.8
—
5.90
—
0
9
0
8
0.00
-0.00
0.0
1.0
—
8.49
—
0
8
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
73
730
1.00
-0.00
2.8
2.8
2.43
2.45
mmol/l
0.70
61
654
6
67
0.89
-0.00
1.2
1.5
—
—
—
0
0
7
78
0.90
-0.00
1.3
1.7
56.10
60.97
ug/l
—
7
63
7
72
0.97
-0.00
3.1
2.6
9.00
7.52
pmol/l
—
7
72
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
3.5
—
50.88
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
12.06
—
0
5
31
310
1.00
-0.00
1.7
1.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
52.40
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
9.9
—
10.26
—
0
8
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
8
82
0.98
-0.00
2.9
1.5
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
9
97
0.93
-0.00
3.0
1.5
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: Q17_ARTERIOVENOUS_MALFORMATION_OF_CEREBRAL_VESSELS – Arteriovenous malformation of cerebral vessels
GWS hits: 1
This endpoint is excluded (different definition than used in FinnGen).